Rapid-response splicing reporter screens identify differential regulators of constitutive and alternative splicing

Molecular and Cellular Biology

Volumn 30, Issue 7, 2010, Pages 1718-1728

  Younis, Ihab ^a   Berg, Michael ^a   Kaida, Daisuke ^a   Dittmar, Kimberly ^a   Wang, Congli ^a   Dreyfuss, Gideon ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDC2 LIKE KINASE; CELL PROTEIN; CHLORHEXIDINE; CLOTRIMAZOLE; FLUNARIZINE; LUCIFERASE; MESSENGER RNA; SERINE ARGININE RICH PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM;

ALTERNATIVE SPLICING; ANTI-INFECTIVE AGENTS, LOCAL; ANTICONVULSANTS; CHLORHEXIDINE; CLOTRIMAZOLE; EXONS; FLUNARIZINE; GENES, REPORTER; HELA CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICROARRAY ANALYSIS; MOLECULAR STRUCTURE; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RNA, MESSENGER;

EID: 77949408107     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01301-09     Document Type: Article

References (65)

1. Alvarez, J., M. Montero, and J. Garcia-Sancho. 1992. High affinity inhibition of Ca(2+)-dependent K+ channels by cytochrome P-450 inhibitors. J. Biol. Chem. 267:11789-11793.
2. Auld, D. S., N. Thorne, W. F. Maguire, and J. Inglese. 2009. Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc. Natl. Acad. Sci. U. S. A. 106:3585-3590.
3. Ben-David, Y., K. Letwin, L. Tannock, A. Bernstein, and T. Pawson. 1991. A mammalian protein kinase with potential for serine/threonine and tyrosine phosphorylation is related to cell cycle regulators. EMBO J. 10:317-325.
4. Benzaquen, L. R., C. Brugnara, H. R. Byers, S. Gatton-Celli, and J. A. Halperin. 1995. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat. Med. 1:534-540.
5. Black, D. L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291-336.
6. Blencowe, B. J. 2006. Alternative splicing: new insights from global analyses. Cell 126:37-47.
7. Bourgeois, C. F., F. Lejeune, and J. Stevenin. 2004. Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of premessenger RNA. Prog. Nucleic Acid Res. Mol. Biol. 78:37-88.
8. Caceres, J. F., G. R. Screaton, and A. R. Krainer. 1998. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev. 12:55-66.
9. Cao, W., S. F. Jamison, and M. A. Garcia-Blanco. 1997. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA 3:1456-1467.
10. Chan, C. C., J. Dostie, M. D. Diem, W. Feng, M. Mann, J. Rappsilber, and G. Dreyfuss. 2004. eIF4A3 is a novel component of the exon junction complex. RNA 10:200-209.
11. Colwill, K., T. Pawson, B. Andrews, J. Prasad, J. L. Manley, J. C. Bell, and P. I. Duncan. 1996. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J. 15:265-275.
12. Cooper, T. A., L. Wan, and G. Dreyfuss. 2009. RNA and disease. Cell 136:777-793.
13. Diem, M. D., C. C. Chan, I. Younis, and G. Dreyfuss. 2007. PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of spliced mRNAs. Nat. Struct. Mol. Biol. 14:1173-1179.
14. Dreyfuss, G., V. N. Kim, and N. Kataoka. 2002. Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 3:195-205.
15. Duncan, P. I., D. F. Stojdl, R. M. Marius, and J. C. Bell. 1997. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Mol. Cell. Biol. 17:5996-6001.
16. Faria, G., C. R. Cardoso, R. E. Larson, J. S. Silva, and M. A. Rossi. 2009. Chlorhexidine-induced apoptosis or necrosis in L929 fibroblasts: a role for endoplasmic reticulum stress. Toxicol. Appl. Pharmacol. 234:256-265.
17. Gallego, M. E., R. Gattoni, J. Stevenin, J. Marie, and A. Expert-Bezancon. 1997. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A. EMBO J. 16:1772-1784.
18. Garcia-Blanco, M. A., A. P. Baraniak, and E. L. Lasda. 2004. Alternative splicing in disease and therapy. Nat. Biotechnol. 22:535-546.
19. Giannelli, M., F. Chellini, M. Margheri, P. Tonelli, and A. Tani. 2008. Effect of chlorhexidine digluconate on different cell types: a molecular and ultrastructural Invest. Toxicol. In Vitro 22:308-317.
20. Graveley, B. R. 2000. Sorting out the complexity of SR protein functions. RNA 6:1197-1211.
21. Gui, J. F., W. S. Lane, and X. D. Fu. 1994. A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369:678-682.
22. Hamalainen, M. L. 2006. Migraine in children and adolescents: a guide to drug treatment. CNS Drugs 20:813-820.
23. Hidalgo, E., and C. Dominguez. 2001. Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol. In Vitro 15:271-276.
24. Kaida, D., H. Motoyoshi, E. Tashiro, T. Nojima, M. Hagiwara, K. Ishigami, H. Watanabe, T. Kitahara, T. Yoshida, H. Nakajima, T. Tani, S. Horinouchi, and M. Yoshida. 2007. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat. Chem. Biol. 3:576-583.
25. Kaminski Schierle, G. S., O. Hansson, and P. Brundin. 1999. Flunarizine improves the survival of grafted dopaminergic neurons. Neuroscience 94:17-20.
26. Kanopka, A., O. Muhlemann, and G. Akusjarvi. 1996. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 381:535-538.
27. Kataoka, N., and G. Dreyfuss. 2004. A simple whole cell lysate system for in vitro splicing reveals a stepwise assembly of the exon-exon junction complex. J. Biol. Chem. 279:7009-7013.
28. Kataoka, N., J. Yong, V. N. Kim, F. Velazquez, R. A. Perkinson, F. Wang, and G. Dreyfuss. 2000. Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding protein that persists in the cytoplasm. Mol. Cell 6:673-682.
29. Khalid, M. H., Y. Tokunaga, A. J. Caputy, and E. Walters. 2005. Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole. J. Neurosurg. 103:79-86.
30. Kojima, T., T. Zama, K. Wada, H. Onogi, and M. Hagiwara. 2001. Cloning of human PRP4 reveals interaction with Clk1. J. Biol. Chem. 276:32247-32256.
31. Kotake, Y., K. Sagane, T. Owa, Y. Mimori-Kiyosue, H. Shimizu, M. Uesugi, Y. Ishihama, M. Iwata, and Y. Mizui. 2007. Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat. Chem. Biol. 3:570-575.
32. Krawczak, M., J. Reiss, and D. N. Cooper. 1992. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90:41-54.
33. Kuroyanagi, N., H. Onogi, T. Wakabayashi, and M. Hagiwara. 1998. Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles. Biochem. Biophys. Res. Commun. 242:357-364.
34. Levinson, N., R. Hinman, A. Patil, C. R. Stephenson, S. Werner, G. H. Woo, J. Xiao, P. Wipf, and K. W. Lynch. 2006. Use of transcriptional synergy to augment sensitivity of a splicing reporter assay. RNA 12:925-930.
35. Licatalosi, D. D., and R. B. Darnell. 2006. Splicing regulation in neurologic disease. Neuron 52:93-101.
36. Manley, J. L., and R. Tacke. 1996. SR proteins and splicing control. Genes Dev. 10:1569-1579.
37. Mayeda, A., and Y. Ohshima. 1990. Beta-globin transcripts carrying a single intron with three adjacent nucleotides of 5′ exon are efficiently spliced in vitro irrespective of intron position or surrounding exon sequences. Nucleic Acids Res. 18:4671-4676.
38. Mayeda, A., G. R. Screaton, S. D. Chandler, X. D. Fu, and A. R. Krainer. 1999. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mol. Cell. Biol. 19:1853-1863.
39. McNally, L. M., and M. T. McNally. 1996. SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. J. Virol. 70:1163-1172.
40. Milstone, A. M., C. L. Passaretti, and T. M. Perl. 2008. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin. Infect. Dis. 46:274-281.
41. Misteli, T., J. F. Caceres, J. Q. Clement, A. R. Krainer, M. F. Wilkinson, and D. L. Spector. 1998. Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J. Cell Biol. 143:297-307.
42. Muraki, M., B. Ohkawara, T. Hosoya, H. Onogi, J. Koizumi, T. Koizumi, K. Sumi, J. Yomoda, M. V. Murray, H. Kimura, K. Furuichi, H. Shibuya, A. R. Krainer, M. Suzuki, and M. Hagiwara. 2004. Manipulation of alternative splicing by a newly developed inhibitor of Clks. J. Biol. Chem. 279:24246-24254.
43. Nott, A., H. Le Hir, and M. J. Moore. 2004. Splicing enhances translation in mammalian cells: an additional function of the exon junction complex. Genes Dev. 18:210-222.
44. O'Brien, K., A. J. Matlin, A. M. Lowell, and M. J. Moore. 2008. The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing. J. Biol. Chem. 283:33147-33154.
45. Oncag, O., M. Hosgor, S. Hilmioglu, O. Zekioglu, C. Eronat, and D. Burhanoglu. 2003. Comparison of antibacterial and toxic effects of various root canal irrigants. Int. Endod. J. 36:423-432.
46. Pan, Q., O. Shai, L. J. Lee, B. J. Frey, and B. J. Blencowe. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40:1413-1415.
47. Pilch, B., E. Allemand, M. Facompre, C. Bailly, J. F. Riou, J. Soret, and J. Tazi. 2001. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res. 61:6876-6884.
48. Rossi, F., E. Labourier, T. Forne, G. Divita, J. Derancourt, J. F. Riou, E. Antoine, G. Cathala, C. Brunel, and J. Tazi. 1996. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 381:80-82.
49. Santi, C. M., F. S. Cayabyab, K. G. Sutton, J. E. McRory, J. Mezeyova, K. S. Hamming, D. Parker, A. Stea, and T. P. Snutch. 2002. Differential inhibition of T-type calcium channels by neuroleptics. J. Neurosci. 22:396-403.
50. Sapra, A. K., M. L. Anko, I. Grishina, M. Lorenz, M. Pabis, I. Poser, J. Rollins, E. M. Weiland, and K. M. Neugebauer. 2009. SR protein family members display diverse activities in the formation of nascent and mature mRNPs in vivo. Mol. Cell 34:179-190.
51. Senapathy, P., M. B. Shapiro, and N. L. Harris. 1990. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol. 183:252-278.
52. Shkreta, L., U. Froehlich, E. R. Paquet, J. Toutant, S. A. Elela, and B. Chabot. 2008. Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes. Mol. Cancer Ther. 7:1398-1409.
53. Soret, J., N. Bakkour, S. Maire, S. Durand, L. Zekri, M. Gabut, W. Fic, G. Divita, C. Rivalle, D. Dauzonne, C. H. Nguyen, P. Jeanteur, and J. Tazi. 2005. Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Proc. Natl. Acad. Sci. U. S. A. 102:8764-8769.
54. Stoilov, P., C. H. Lin, R. Damoiseaux, J. Nikolic, and D. L. Black. 2008. A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc. Natl. Acad. Sci. U. S. A. 105:11218-11223.
55. Sumanasekera, C., D. S. Watt, and S. Stamm. 2008. Substances that can change alternative splice-site selection. Biochem. Soc. Trans. 36:483-490.
56. Takahashi, H., M. Abe, T. Sugawara, K. Tanaka, Y. Saito, S. Fujimura, M. Shibuya, and Y. Sato. 1998. Clotrimazole, an imidazole antimycotic, is a potent inhibitor of angiogenesis. Jpn. J. Cancer Res. 89:445-451.
57. Venables, J. P. 2004. Aberrant and alternative splicing in cancer. Cancer Res. 64:7647-7654.
58. Villalobos, C., R. Fonteriz, M. G. Lopez, A. G. Garcia, and J. Garcia-Sancho. 1992. Inhibition of voltage-gated Ca2+ entry into GH3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers. FASEB J. 6:2742-2747.
59. Wahl, M. C., C. L. Will, and R. Luhrmann. 2009. The spliceosome: design principles of a dynamic RNP machine. Cell 136:701-718.
60. Wang, E. T., R. Sandberg, S. Luo, I. Khrebtukova, L. Zhang, C. Mayr, S. F. Kingsmore, G. P. Schroth, and C. B. Burge. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476.
61. Wang, J., and J. L. Manley. 1995. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1:335-346.
62. Wang, Z., and C. B. Burge. 2008. Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14:802-813.
63. Wiegand, H. L., S. Lu, and B. R. Cullen. 2003. Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. Proc. Natl. Acad. Sci. U. S. A. 100:11327-11332.
64. Xiao, S. H., and J. L. Manley. 1997. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 11:334-344.
65. Yesilsoy, C., E. Whitaker, D. Cleveland, E. Phillips, and M. Trope. 1995. Antimicrobial and toxic effects of established and potential root canal irrigants. J. Endod. 21:513-515.